LIPOHYPERTROPHY

Clinical trials for LIPOHYPERTROPHY explained in plain language.

Never miss a new study

Get alerted when new LIPOHYPERTROPHY trials appear

Sign up with your email to follow new studies for LIPOHYPERTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1 Terminated 2

Could a diabetes drug shrink dangerous belly fat in HIV patients?

Disease control Ongoing

This study tests whether semaglutide, a drug used for diabetes, can reduce harmful belly fat and improve heart health in people with HIV who have excess fat around the midsection (lipohypertrophy). About 108 participants will receive either semaglutide or a placebo for 32 weeks. …

Matched conditions: LIPOHYPERTROPHY

Phase: PHASE2 • Sponsor: Case Western Reserve University • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

LIPOHYPERTROPHY

Get alerted when new LIPOHYPERTROPHY trials appear

Could a diabetes drug shrink dangerous belly fat in HIV patients?